This is a preview of subscription content, log in via an institution to check access.
References
Jemal A, Siegel R, Ward E et al (2007) Cancer statistics. CA Cancer J Clin 57:43–66
De Leyn P, Lardinois D, Van Schil P et al (2007) European trends in preoperative and intraoperative staging: ETS guidelines. J Thorac Oncol 2:357–361
Mountain CF (1997) Revisions in the International System for Staging Lung Cancer. Chest 111:1710–1717
Goldstraw P, Crowley J, Chansky K et al (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2:706–714
Douillard JY, Rosell R, De Lena M et al (2006) Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7:719–727
Pignon JP, Tribodet H, Scagliotti GV et al (2008) Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552–3559
Rosell R, Gomez Codina J, Camps C et al (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153–158
Albain K, Swan S, Rush V et al (2005) Phase III study of concurrent chemotherapy and radiotherapy versus chemotherapy and radiotherapy followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer: outcome updates of North America Intergroup 0139. Proc Am Soc Clin Oncol 23;624s (LBA 7014)
Hanna N, Neubauer M, Yiannoutsos C et al (2008) Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26:5755–5760
Vokes E, Herdorn J, Kelley M et al (2007) Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 25:1698–1704
D’Addario G, Felip E (2008) Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 19[Suppl 2]:ii39–ii40
Sandler AB, Gray R, Perry MC et al (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer. N Engl J Med 355: 2542–2550
Scagliotti GV, Parikh P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naïve patients with advanced-stage NSCLC. J Clin Oncol 26:3543–3551
Author information
Authors and Affiliations
Consortia
Additional information
Supported by an unrestricted educational grant from MSD Oncology
Clinical Guideline Working Group on behalf of the Spanish Society of Medical Oncology (SEOM) Executive Committee 2007–2009: Ramón Colomer, Emilio Alba, Antonio Llombart, Miguel Martín, Álvaro Rodríguez, Javier Salvador, Joan Albanell, Antonio González, Dolores Isla, María Lomas, César A. Rodríguez, José Manuel Trigo
Rights and permissions
About this article
Cite this article
Felip, E., Garrido, P., Trigo, J.M. et al. SEOM guidelines for the management of non-small-cell lung cancer (NSCLC). Clin Transl Oncol 11, 284–289 (2009). https://doi.org/10.1007/s12094-009-0356-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-009-0356-4